Gene · 84464
Papers1,453
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,453
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antibody-Drug Conjugates in Breast Cancer: Ascent to Destiny and Beyond-A 2023 Review. | Curr Oncol | 2023 | 37504334 | PubTator, text mining | PubMed |
| Distinct characteristics of two types of alternative lengthening of telomeres in mouse embryonic stem cells. | Nucleic Acids Res | 2023 | 37496110 | PubTator, text mining | PubMed |
| Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial. | Nat Med | 2023 | 37488289 | PubTator, text mining | PubMed |
| The SUMO-NIP45 pathway processes toxic DNA catenanes to prevent mitotic failure. | Nat Struct Mol Biol | 2023 | 37474739 | PubTator, text mining | PubMed |
| Management of patients with HER2-positive metastatic breast cancer after trastuzumab deruxtecan failure. | ESMO Open | 2023 | 37467660 | PubTator, text mining | PubMed |
| Regulation of Rad52-dependent replication fork recovery through serine ADP-ribosylation of PolD3. | Nat Commun | 2023 | 37463936 | PubTator, text mining | PubMed |
| Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer. | J Ovarian Res | 2023 | 37460928 | PubTator, text mining | PubMed |
| ATR protects ongoing and newly assembled DNA replication forks through distinct mechanisms. | Cell Rep | 2023 | 37454295 | PubTator, text mining | PubMed |
| The Adaptive Mechanisms and Checkpoint Responses to a Stressed DNA Replication Fork. | Int J Mol Sci | 2023 | 37445667 | PubTator, text mining | PubMed |
| Partial Response to Crizotinib in a Lung Adenocarcinoma Patient with a Novel FBXO11 (Intergenic)-ALK (Exon 20-29) Fusion. | Onco Targets Ther | 2023 | 37441362 | PubTator, text mining | PubMed |
| Antibody-drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatment. | Ther Adv Med Oncol | 2023 | 37435563 | PubTator, text mining | PubMed |
Lobular Endocervical Glandular Hyperplasia, a mimicker and potential pitfall for HPV-independent well differentiated Gastric-type Endocervical Adenocarcinoma: Case report and literature review focusing on histology, immunophenotype, and molecular findings. | SAGE Open Med Case Rep | 2023 | 37434896 | PubTator, text mining | PubMed |
| DNA double-strand break genetic variants in patients with premature ovarian insufficiency. | J Ovarian Res | 2023 | 37430352 | PubTator, text mining | PubMed |
| Structural underpinnings of mutation rate variations in the human genome. | Nucleic Acids Res | 2023 | 37395403 | PubTator, text mining | PubMed |
| Molecular typing and mutational characterization of rectal neuroendocrine neoplasms. | Cancer Med | 2023 | 37387515 | PubTator, text mining | PubMed |
| A signal-seeking Phase 2 study of olaparib and durvalumab in advanced solid cancers with homologous recombination repair gene alterations. | Br J Cancer | 2023 | 37365284 | PubTator, text mining | PubMed |
| Nuclear myosin VI maintains replication fork stability. | Nat Commun | 2023 | 37355687 | PubTator, text mining | PubMed |
| Possible molecular mechanisms underlying the development of atherosclerosis in cancer survivors. | Front Cardiovasc Med | 2023 | 37332576 | PubTator, text mining | PubMed |
| Phosphoregulation of DNA repair via the Rad51 auxiliary factor Swi5-Sfr1. | J Biol Chem | 2023 | 37330173 | PubTator, text mining | PubMed |
| An acquired BMF with FANCL gene heterozygous mutation: Case report. | Medicine (Baltimore) | 2023 | 37327301 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84464/papers?page=8